These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 25505789)

  • 61. Extrapulmonary uterine lymphangioleiomyomatosis (LAM) and dysfunctional uterine bleeding: the first presentation of LAM in a tuberous sclerosis complex patient.
    Grant L; Chipwete S; Soo Hoo S; Bhatnagar A
    BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30804158
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.
    Liu HJ; Lizotte PH; Du H; Speranza MC; Lam HC; Vaughan S; Alesi N; Wong KK; Freeman GJ; Sharpe AH; Henske EP
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669930
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CT of sclerotic bone lesions: imaging features differentiating tuberous sclerosis complex with lymphangioleiomyomatosis from sporadic lymphangioleiomymatosis.
    Avila NA; Dwyer AJ; Rabel A; Darling T; Hong CH; Moss J
    Radiology; 2010 Mar; 254(3):851-7. PubMed ID: 20177097
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex.
    Schiavina M; Di Scioscio V; Contini P; Cavazza A; Fabiani A; Barberis M; Bini A; Altimari A; Cooke RM; Grigioni WF; D'Errico-Grigioni A
    Am J Respir Crit Care Med; 2007 Jul; 176(1):96-8. PubMed ID: 17431222
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex.
    Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ
    Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lymphangioleiomyomatosis screening in women with tuberous sclerosis.
    Cudzilo CJ; Szczesniak RD; Brody AS; Rattan MS; Krueger DA; Bissler JJ; Franz DN; McCormack FX; Young LR
    Chest; 2013 Aug; 144(2):578-585. PubMed ID: 23539171
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM).
    Liu J; Zhao W; Ou X; Zhao Z; Hu C; Sun M; Liu F; Deng J; Gu W; An J; Zhang Q; Zhang X; Xie J; Li S; Chen R; Yu S; Zhong N
    PLoS One; 2019; 14(12):e0226400. PubMed ID: 31856217
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Emerging biomarkers of lymphangioleiomyomatosis.
    Nijmeh J; El-Chemaly S; Henske EP
    Expert Rev Respir Med; 2018 Feb; 12(2):95-102. PubMed ID: 29171770
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of beta-agonists on LAM progression and treatment.
    Le K; Steagall WK; Stylianou M; Pacheco-Rodriguez G; Darling TN; Vaughan M; Moss J
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E944-E953. PubMed ID: 29339522
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lymphangioleiomyomatosis with Tuberous Sclerosis Complex-A Case Study.
    Marciniak A; Nawrocka-Rutkowska J; Brodowska A; Starczewski A; Szydłowska I
    J Pers Med; 2023 Nov; 13(11):. PubMed ID: 38003913
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lymphangioleiomyomatosis: A review.
    Hohman DW; Noghrehkar D; Ratnayake S
    Eur J Intern Med; 2008 Jul; 19(5):319-24. PubMed ID: 18549932
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rapalog resistance is associated with mesenchymal-type changes in Tsc2-null cells.
    Valianou M; Filippidou N; Johnson DL; Vogel P; Zhang EY; Liu X; Lu Y; Yu JJ; Bissler JJ; Astrinidis A
    Sci Rep; 2019 Feb; 9(1):3015. PubMed ID: 30816188
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinicopathological Impacts of Expression of Neuronal Markers in Lymphangioleiomyomatosis.
    Kishi M; Hayashi T; Mitani K; Tsuboshima K; Kurihara M; Hosoya M; Sekimoto Y; Okura MK; Mitsuishi Y; Okada Y; Kanno J; Yao T; Takahashi K; Seyama K
    Am J Surg Pathol; 2023 Nov; 47(11):1252-1260. PubMed ID: 37599567
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
    Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Possible Novel Therapeutic Targets in Lymphangioleiomyomatosis Treatment.
    Song X; Cai H; Yang C; Xue X; Wang J; Mo Y; Zhu M; Zhu G; Ye L; Jin M
    Front Med (Lausanne); 2020; 7():554134. PubMed ID: 33072782
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Successful factor XIII treatment of refractory chylothorax in tuberous sclerosis complex-associated lymphangioleiomyomatosis, multifocal multinodular pneumocyte hyperplasia and mediastinal lymphadenopathy.
    Sreter KB; Barisic B; Light RW
    Lymphology; 2017; 50(4):183-187. PubMed ID: 30248722
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical, tomographic and functional comparison of sporadic and tuberous sclerosis complex-associated forms of lymphangioleiomyomatosis: a retrospective cohort study.
    Oliveira MR; Wanderley M; Freitas CSG; Kairalla RA; Chate RC; Amaral AF; Arimura FE; Samorano LP; Watanabe EH; Carvalho CRR; Baldi BG
    ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38444661
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients.
    Hayashi T; Kumasaka T; Mitani K; Terao Y; Watanabe M; Oide T; Nakatani Y; Hebisawa A; Konno R; Takahashi K; Yao T; Seyama K
    Am J Surg Pathol; 2011 Dec; 35(12):1776-85. PubMed ID: 22020043
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
    Makovski V; Jacob-Hirsch J; Gefen-Dor C; Shai B; Ehrlich M; Rechavi G; Kloog Y
    Cell Death Dis; 2014 Dec; 5(12):e1557. PubMed ID: 25476905
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Selected case from the Arkadi M. Rywlin International Pathology Slide Seminar: Sporadic lymphangioleiomyomatosis.
    Bisceglia M; D'Alessandro V; Simeone A; Ben-Dor D; Pasquinelli G
    Adv Anat Pathol; 2010 Nov; 17(6):445-52. PubMed ID: 20966650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.